GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bonus Biogroup BONS.TA · ILA

Health Care · Tel Aviv · 🇮🇱 Israel

Compare

15.80

0.00%

Close of 9 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in ILS, from our data supplier.

FY2025

Net income

−ILS 24.5m

FY2016FY2025

Free cash flow

−ILS 14.9m

FY2016FY2025

Shareholders' equity

−ILS 5.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross profit−ILS 2.8m−ILS 2.8m−ILS 2.8m−ILS 33,660−ILS 40,970−ILS 16,090——−ILS 13,410−ILS 1.1m
Research and developmentILS 11.2mILS 17.6mILS 18.6mILS 213,120ILS 195,090ILS 103,540ILS 110,830ILS 108,240ILS 108,860ILS 8.6m
Operating income−ILS 22.6m−ILS 27.8m−ILS 28.3m−ILS 370,470−ILS 894,820−ILS 215,480−ILS 209,090−ILS 184,500−ILS 201,300−ILS 16.0m
Net income−ILS 24.5m−ILS 27.8m−ILS 28.5m−ILS 387,030−ILS 900,760−ILS 220,210−ILS 222,400−ILS 187,350−ILS 201,970−ILS 16.0m
Diluted earnings per share-0.02-0.04-0.02-0.00-0.00-0.00-0.00-0.00-0.00-0.07

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsILS 15.4mILS 23.4mILS 44.9mILS 746,100ILS 1.0mILS 514,370ILS 69,900ILS 101,580ILS 55,770ILS 2.9m
Cash and short-term investmentsILS 228,000ILS 6.9mILS 12.9mILS 536,240ILS 794,530ILS 160,860ILS 1,050ILS 86,410ILS 27,250ILS 1.4m
Total liabilitiesILS 21.1mILS 16.4mILS 15.6mILS 182,210ILS 198,920ILS 207,530ILS 207,110ILS 133,350ILS 119,610ILS 10.3m
DebtILS 8.9mILS 10.2mILS 11.2mILS 119,520ILS 123,500ILS 51,540ILS 58,760———
Shareholders' equity−ILS 5.7mILS 7.0mILS 29.3mILS 563,890ILS 844,300ILS 306,840−ILS 137,210−ILS 31,770−ILS 63,840−ILS 7.4m
Shares outstanding1,168m699m1,168m1,168m1,154m999m841m811m810m234m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−ILS 14.9m−ILS 21.4m−ILS 26.4m−ILS 288,150−ILS 398,390−ILS 157,460−ILS 131,130−ILS 134,270−ILS 118,230−ILS 9.6m
Capital spending−ILS 12,000−ILS 342,000−ILS 824,000−ILS 63,890−ILS 58,090−ILS 2,540−ILS 1,870−ILS 3,410−ILS 2,690−ILS 191,000
Free cash flow−ILS 14.9m−ILS 21.7m−ILS 27.2m−ILS 352,040−ILS 456,480−ILS 160,000−ILS 133,000−ILS 137,680−ILS 120,920−ILS 9.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Gross profit——————−ILS 702,000−ILS 698,000
Operating income−ILS 5.8m−ILS 5.8m−ILS 5.7m−ILS 5.7m−ILS 6.1m−ILS 6.1m−ILS 5.7m−ILS 6.7m
Net income−ILS 6.0m−ILS 6.0m−ILS 5.9m−ILS 5.9m−ILS 6.3m−ILS 6.3m−ILS 5.9m−ILS 7.0m
Diluted earnings per share-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01
Cash from operations−ILS 4.0m−ILS 4.0m−ILS 3.0m−ILS 3.0m−ILS 4.0m−ILS 4.0m−ILS 4.0m−ILS 5.0m
Total assetsILS 14.2mILS 14.2mILS 15.4mILS 15.4mILS 17.3mILS 17.3mILS 23.4mILS 26.4m
Cash and short-term investmentsILS 439,000ILS 439,000ILS 228,000ILS 228,000ILS 1.2mILS 1.2mILS 6.9mILS 8.7m
DebtILS 1.9mILS 1.9mILS 1.8mILS 1.8mILS 1.7mILS 1.7mILS 1.7mILS 1.6m
Shareholders' equity−ILS 8.5m−ILS 8.5m−ILS 5.7m−ILS 5.7m−ILS 1.7m−ILS 1.7mILS 7.0mILS 8.8m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income293.9%153.7%5.4%
Net income298.5%156.6%6.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-12.0-3.0-6.9-579.4-1614.3-2195.7-1683.7-1607.0-2196.8-8.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 3 Jun 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.